 | |
| Clinical data | |
|---|---|
| Routes of administration | Oral |
| ATC code |
|
| Legal status | |
| Legal status |
|
| Identifiers | |
| |
| CAS Number |
|
| PubChemCID | |
| ChemSpider | |
| UNII | |
| ChEMBL | |
| CompTox Dashboard(EPA) | |
| Chemical and physical data | |
| Formula | C22H31NO4 |
| Molar mass | 373.493 g·mol−1 |
| 3D model (JSmol) | |
| |
| |
Fedotozine (INN;JO 1196 for the (-) tartrate salt) is anopioiddrug which acts as aperipherally specificselectiveκ1-opioid receptoragonist with preference for the κ1A subtype.[1] It was under investigation for the treatment ofgastrointestinalconditions likeirritable bowel syndrome andfunctional dyspepsia and made it tophase IIIclinical trials,[1][2][3] but ultimately development was discontinued and it was never marketed.
